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Abstract
Sestrins (Sesn1/2/3) belong to a small protein family that has versatile biological functions. In 
addition to initially characterized oxidoreductase activity, sestrins also have oxidoreductase-
independent functions, including activation of AMP-activated protein kinase (AMPK), inhibition 
of mechanistic target of rapamycin complex 1 (mTORC1), and activation of mTORC2. As these 
kinases are important for metabolic regulation, sestrins have a favorable profile as potential 
therapeutic targets for metabolic diseases such as diabetes. Recent data are in line with such a 
notion. In this editorial, I have attempted to provide some brief update on the major findings in 
regard to sestrins in metabolism.
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Sestrins – Regulators for AMPK and mTORC1
Sestrin proteins belong to a small family that is composed of three members (Sesn1/2/3) in 
mammals. The three sestrins share over 50% identical amino acid sequences throughout the 
entire proteins and ∼70% in the carboxyl-terminal 145 amino acids (Figure 1). The amino 
acid sequences flanking the proposed catalytic cysteine (SESN1-C189, SESN2-C125, and 
SESN3-121) are completely identical among all three human sestrin proteins (Figure 1). By 
comparing with other proteins using a bioinformatics tool, the amino-terminal of the sestrin 
proteins share some similarity to a catalytic motif in prokaryotic proteins such as 
Mycobacterium tuberculosis AhpD, a component of alkyl-hydroperoxide reductase 1. 
Although sestrins have been shown to protect cells from oxidative stress, it is not clear 
whether the intrinsic enzymatic activity is required 1-3. However, more and more data 
suggest that sestrins have catalytic activity-independent functions. It has been reported that 
Sesn 1 and Sesn2 can activate AMP-activated protein kinase (AMPK) through a direct 
interaction with the α-subunits of the AMPK complex 4. In the same study, Sesn1 and Sesn2 
have also been shown to inhibit the activity of mechanistic target of rapamycin complex 1 
(mTORC1), and the inhibition was proposed through the phosphorylation of tuberous 
sclerosis 2 (TSC2). Recently, it has been found that sestrins can modulate mTORC1 activity 
through at least two other mechanisms: 1) sestrins inhibit amino acid-induced RagA/B (Ras-
related GTP binding A/B) guanine nucleotide exchange and mTORC1 translocation to the 
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lysosome 5; 2) sestrins inhibit mTORC1 lysosomal translocation via interaction with the 
mTORC1 upstream regulator GATOR2 (GTPase-activating protein (GAP) activity toward 
Rags subcomplex2) 6, 7 (Figure 2).
Since both AMPK and mTORC1 play critical roles in energy and nutrient homeostasis, as an 
upstream regulator of these two kinases, sestrins have been implicated in a number of 
biological processes (Figure 2). Sestrins have been shown to protect cells or organisms 
against oxidative stress through either their intrinsic enzymatic activity or a Nrf2 (also called 
Nfe2l2, nuclear factor erythroid 2-like 2)-mediated transcriptional response 1, 2, 8. Sestrins, 
especially Sesn2, are also protective against overnutrition-induced ER stress, possibly 
through inhibition of mTORC1 9. Sestrins play a critical role in the activation of autophagy, 
an essential cellular maintenance process, through multiple mechanisms including activation 
of AMPK, inhibition of mTORC1, and activation of ULK1 (unc-51-like autophagy 
activating kinase 1) and sequestosome 1 (Sqstm1 or p62) 2, 8, 10. Furthermore, sestrins are 
also important regulators for metabolic homeostasis. Sesn2 and Sesn3 have been shown to 
suppress hepatic glucose production and promote glucose and lipid metabolism 2, 8, 11-13.
Sestrins– Remarkable Insulin Sensitizers
Recently, Sesn2 and Sesn3 have been shown to enhance insulin action in mouse models. 
Systemic deficiency of Sesn2 leads to worse glucose and insulin tolerance in high-fat-diet 
induced obese or genetic leptin-deficient ob/ob mouse models 12. It has been suggested that 
downregulated AMPK and overactivated mTORC1 might be responsible for the metabolic 
dysregulation when Sesn2 becomes deficient 12. In another study using liver-specific Sesn3 
knockout and transgenic mouse models, it has been demonstrated that hepatic Sesn3 
deficiency also causes insulin resistance and glucose intolerance under either regular chow 
or high-fat diet conditions 13. Conversely, Hepatic Sesn3 overexpression improves insulin 
sensitivity and glucose homeostasis in transgenic mice under chow and high-fat diet 
conditions 13. Intriguingly, AMPK does not seen to play a major role in the effects of Sesn3 
on insulin sensitivity and glucose metabolism since hepatic Sesn3 overexpression in 
AMPKα1/2 liver-specific double knockout mice shows the same effects as in the wild-type 
mice. Further biochemical analysis reveals a role of Sesn3 in the regulation of the mTORC2-
Akt (also called PKB, protein kinase B) signaling 13. The activation of Akt kinase requires 
two distinct phosphorylations – Thr308 and Ser473, catalyzed by two different kinases, 
Pdk1 (also called Pdpk1, 3-phosphoinositide-dependent protein kinase 1) and mTORC2, 
respectively. Although it is not completely clear in molecular details, Sesn3 has been 
observed to interact with Rictor (rapamycin-insensitive companion of mTOR), an essential 
component of the mTORC2 complex. Such an interaction enhances the mTORC2 activity 
toward the Akt kinase 13. Interestingly, Rosiglitazone, a peroxisome proliferator-activated 
receptor γ (PPARγ) agonist and known insulin sensitizer, has been shown to upregulate 
Sesn1 in retinal cells 14; however, it is not known whether the same effect occurs in other 
cell types. In addition, Sesn2 protein is stabilized by insulin in hepatocytes through the 
PI3K-mTORC1 pathway 15. Intriguingly, acute Sesn2 knockdown also decreases 
phosphatase and tensin homolog (PTEN) and increases insulin signaling in hepatocytes 15. 
However, chronic Sesn2 deficiency leads to insulin resistance in mice 12. How Sesn2 plays 
different roles under those conditions is not clear.
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It can be envisioned that sestrin deficiency and/or functional impairment could lead to 
insulin resistance and metabolic disorders such as diabetes. Interestingly, three sestrin genes 
have different responses to overnutrition, Sesn2 is induced by a high-fat diet in the liver and 
skeltal muscle of mice whereas Sesn1 is decreased in the skeletal muscle and Sesn3 is 
decreased in both the liver and adipose tissue but is increased in the skeletal muscle under 
the high-fat diet condition and the leg muscle biopsies of human diabetics 12, 16. To date, the 
major metabolic phenotypes from Sesn2 and Sesn3 knockout mice have been related to their 
hepatic functions. Thus, it has been proposed that sestrins could be the missing link in the 
selective hepatic insulin resistance whereby insulin continues to promote lipid biosynthesis 
but it is unable to suppress hepatic glucose production 17. When the functions of sestrins are 
impaired, the mTORC1 activity is expected to increase and so is lipid and protein synthesis. 
At the same time, due to decreased activation of the mTORC2 complex by sestrins, Akt 
might not be sufficiently activated to control the activity of Foxos (forkhead box O) that are 
crucial transcription factors for hepatic gluconeogenesis. Therefore, hepatic glucose 
production is elevated under insulin resistance.
Conclusion
Sestrins play a critical role in metabolic control and glucose homeostasis through activation 
of AMPK and mTORC2 and inhibition of mTORC1. Therefore, Sesn1/2/3 may represent a 
novel class of potential targets for therapeutic intervention of diabetes and metabolic 
syndrome.
Expert opinion
In my view, the research on sestrin biology has made remarkable progress in the last decade 
with a number of discoveries. First, sestrins are important defense factors against both 
endogenous and exogenous oxidative stress although the underlying mechanisms are 
incompletely understood. Second, sestrins can activate the key energy sensor AMPK and 
thus are critical for energy homeostasis. Third, sestrins inhibit mTORC1 translocation to the 
lysosome. This important regulation allows sestrins to modulate nutrient homeostasis, 
activate autophagy and suppress ER stress as well. Finally, sestrins can activate mTORC2 
and thus sensitize insulin action. Overall, sestrins have salutary functions for metabolic 
homeostasis and hold exciting potentials for therapeutic applications including type 2 
diabetes treatment.
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highlights box
• Sestrins are a rheostat for metabolic control.
• Sestrins activate the energy sensor AMPK during fasting.
• Sestrins suppress the mTORC1 activity during feeding.
• Sestrins sensitize insulin action via activation of the mTORC2 signaling.
• Sestrins control both glucose and lipid metabolism.
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Figure 1. Human sestrin proteins share high similarity in primary sequences
Human SESN1/2/3 protein sequences (Accession numbers: NP_055269, NP_113647, and 
NP_653266) were aligned using ClustalW2 program on the EMBL-EBI website. * indicates 
an identical amino acid among all three sestrins. The proposed catalytic cysteine residue is 
highlighted in a box.
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Figure 2. Signaling pathways regulated by sestrins in metabolism
Sestrins have been shown to regulate multiple signaling pathways that are important for 
metabolic homeostasis. Early on, AMPK was identified as a downstream kinase for the 
regulation of stress response to energy deprivation, reactive oxygen species, and genotoxins. 
It was also suggested that inhibition of mTORC1 by AMPK could play a critical role in 
those stress conditions. Later, it has been observed that sestrins can inhibit mTORC1 
independently of AMPK, through either a direct inhibition of RagA/B GTPases or an 
indirect inhibition of RagA/B via GATOR2. Consequently, sestrins suppress the mTORC1 
activity. Moreover, Sesn3 has been found to enhance insulin signaling through an activation 
of mTORC2. 4E-BP, eukaryotic translation initiation factor 4E binding protein 1; Akt, v-akt 
murine thymoma viral oncogene homolog; Akt1s1, Akt1 substrate 1; AMPK, AMP-
activated protein kinase; DEPDC5, DEP domain containing 5; Deptor, DEP domain 
containing mTOR-interacting protein; ER, endoplasmic reticulum; FFA, free fatty acids; 
FOXO, forkhead box O; GATOR, GTPase-activating protein (GAP) activity toward Rags; 
GS, glycogen synthase; GSK3, glycogen synthase kinase 3; IR, insulin receptor; IRS, insulin 
receptor substrate; Keap1, kelch-like ECH-associated protein 1; Mapkap1, also called SIN1, 
mitogen-activated protein kinase associated protein 1; Mios, missing oocyte meiosis 
regulator homolog; mLST8, mTOR associated protein LST8 homolog; mTOR, mechanistic 
target of rapamycin; Nprl, nitrogen permease regulator-like; Nrf2, also called Nfe2l2, 
nuclear factor erythroid 2-like 2; PDK1, 3-phosphoinositide-dependent protein kinase 1; 
PI3K, phosphatidylinositol-4,5-bisphophate 3-kinase; Prr5, also called Protor 1, proline rich 
5; Rag, Ras-relatedGTP binding; Rptor, also called Raptor, regulatory associated protein of 
mTORC1; Rheb, Ras homolog enriched in brain; Rictor, Rptor-independent companion of 
mTORC2; S6K1, also called RPS6KB1,, ribosomal protein S6 kinase polypeptide 1; Sec13, 
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SEC13 homolog; Seh1L, SEH1-like;Sqstm1, sequestosome 1, also called p62; TBC1D4, 
TBC1 domain family member 4; TSC, tuberous sclerosis complex; ULK1, unc-51-like 
autophagy activating kinase 1; WDR, WD repeat domain.
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